Influence of various variables on stabilisation of the neurological disease
| Factor | Stable at last follow up N (%) | p value |
|---|---|---|
| *p<0.05. | ||
| †p value calculated using Fisher’s exact test. | ||
| Sex | ||
| Male | 6 (43) | |
| Female | 17 (38) | 0.73 |
| Age of onset | ||
| ⩽60 years | 7 (44) | |
| >60 years | 16 (37) | 0.65 |
| Presentation | ||
| Tumour | 1 (14) | |
| Neurology | 22 (42) | 0.23† |
| Clinical phenotype | ||
| Unifocal | 15 (40) | |
| Multifocal | 8 (38) | 1.00† |
| Tumour treatment | ||
| Yes | 18 (50) | |
| No | 5 (21) | 0.03* |
| Antineuronal antibody status | ||
| +ve | 18 (44) | |
| −ve | 3 (27) | 0.49† |
| Oligoclonal bands | ||
| +ve | 9 (38) | |
| −ve | 3 (60) | 0.62† |